These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38490332)

  • 1. Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention.
    Reid S; Nichols R; Veach S; Alhersh E; Witry M
    J Am Pharm Assoc (2003); 2024; 64(3):102067. PubMed ID: 38490332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention.
    Reid S; Nichols R; Veach S; Alhersh E; Witry M
    J Am Pharm Assoc (2003); 2024; 64(4S):102180. PubMed ID: 39127944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing a pharmacist provided mental health screening service in a rural community to address anxiety and depression.
    Jewell TM; Kowalski A; Lahrman R
    J Am Pharm Assoc (2003); 2024; 64(4S):102103. PubMed ID: 38649094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
    Rosser S; Frede S; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2013; 53(1):22-9. PubMed ID: 23636152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of mental health clinical pharmacist independent prescribers within general practice in remote and rural Scotland.
    Buist E; McLelland R; Rushworth GF; Stewart D; Gibson-Smith K; MacLure A; Cunningham S; MacLure K
    Int J Clin Pharm; 2019 Oct; 41(5):1138-1142. PubMed ID: 31493208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a brief screening tool for medication-related problems.
    Snyder ME; Pater KS; Frail CK; Hudmon KS; Doebbeling BN; Smith RB
    Res Social Adm Pharm; 2015; 11(2):253-64. PubMed ID: 25443640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.
    Kerstenetzky L; Heimerl KM; Hartkopf KJ; Hager DR
    J Am Pharm Assoc (2003); 2018; 58(5):540-546. PubMed ID: 30017369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feasibility study of community pharmacists performing depression screening services.
    O'Reilly CL; Wong E; Chen TF
    Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression screening in adults by pharmacists in the community: a systematic review.
    Miller P; Newby D; Walkom E; Schneider J; Li SC
    Int J Pharm Pract; 2020 Oct; 28(5):428-440. PubMed ID: 32776433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
    Wilson C; Twigg G
    J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
    Nusair MB; Guirguis LM
    Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.